» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Innovative COVID‑19 response: Dal Med Human Body Donation Program contributes to airway training
- Grad Profiles: Closing the curtains on a Euphoric four years
- Researchers at Dalhousie to lead human trials of COVID‑19 vaccine
- Med students find ways to give back during COVID‑19
- Medical education in the time of COVID‑19: Dal Med takes doctor training online; clerks step up to volunteer
- Dalhousie Neurosurgery Resident Receives Top Prize for Clinical Neuroscience Research
- Facing the new coronavirus: Dalhousie researchers help galvanize scientific response to the new pandemic
- EUPHORIA! 2020